W
IDXX icon

Wealthfront’s Idexx Laboratories IDXX Stock Holding History

Wealthfront’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$541K Buy
2,167
+432
+25% +$105K 0.01% 367
2018
Q2 		$378K Sell
1,735
-6
-0.3% -$1.24K ﹤0.01% 404
2018
Q1 		$333K Buy
1,741
+438
+34% +$80.8K ﹤0.01% 426
2017
Q4 		$204K Sell
1,303
-1,004
-44% -$158K ﹤0.01% 493
2017
Q3 		$359K Buy
2,307
+760
+49% +$120K ﹤0.01% 391
2017
Q2 		$250K Buy
+1,547
New +$251K ﹤0.01% 409
2015
Q4 		– Sell
-500
Closed -$37K – 633
2015
Q3 		$37K Buy
500
+60
+14% +$4.3K ﹤0.01% 567
2015
Q2 		$28K Buy
440
+380
+633% +$26.3K ﹤0.01% 571
2015
Q1 		$5K Buy
60
+56
+1,400% +$4.36K ﹤0.01% 788
2014
Q4 		$0 Buy
+4
New +$281 ﹤0.01% 817

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Wealthfront's IDXX Position: Q3 2018 in Review

Wealthfront increased its Idexx Laboratories (IDXX) stake by 25% in Q3 2018, buying an estimated $105K and bringing the position to 2,167 shares worth $541K. The position accounts for 0.01% of the portfolio, ranked #367.

Wealthfront first reported a position in IDXX in Q4 2014 and has held it in 10 quarters since. 698 funds tracked by Wall St. Rank hold IDXX as of Q3 2018.

  • Wealthfront held 2,167 shares of Idexx Laboratories worth $541K as of Q3 2018.
  • Wealthfront bought 432 Idexx Laboratories shares in Q3 2018, an estimated $105K.
  • Idexx Laboratories made up 0.01% of Wealthfront's portfolio in Q3 2018, its #367 holding.
  • Wealthfront first reported a position in Idexx Laboratories in Q4 2014 and has held it in 10 quarters since.
  • 698 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2018.

Based on Wealthfront's 13F filing for Q3 2018, filed 13 Nov 2018.